Bridging science and patient care for acute challenges
Innovation
Our diagnostic innovations
We address diagnostic blind spots by developing innovative biomarkers to support early intervention and personalized medicine in critical care.
Products
The products
We offer biomarker assays for research use and, through our licensing partners, make IVD products available for clinical diagnostics worldwide.
Collaborations
Biomarker outlicensing
For a broad market adoption of our first-in-class biomarkers, we partner with global IVD companies wishing to enrich their immunoassay portfolios.
Collaboration
Pharma collaborations
Our biomarkers can provide a solution for enrichment and increased efficacy strategies in critical care drug discovery to de-risk drug developments.
